• Dystonia (DYT1)

• Familial Amyotrophic Lateral Sclerosis (FALS; SOD1 mutation)
• Hypokalemic Periodic Paralysis (HOPP)
• Hyperkalemic Periodic Paralysis (HYPP)
• Infantile Neuronal Ceroid Lipofuscinosis (INCL, CLN1)
• Late Infantile Neuronal Ceroid Lipofuscinosis (LINCL, CLN2)
• Juvenile Neuronal Ceroid Lipofuscinosis (JNCL, CLN3, Batten disease]
• Neurofibromatosis type 2 (NF2) [mutation screening; linkage]
• Norrie disease (ND)
• Tuberous Sclerosis (TSC1 and TSC2)
• Huntington disease (HD)
• Friederichs Ataxia (FA)
• Spinocerebellar ataxias: SCA1, SCA2, SCA6, SCA7
• Machado-Joseph disease (MJD; SCA3)
• Dentatorubral-pallidoluysian atrophy (DRPLA)
• Paternity
• chromosome 1p allele loss
  

Technology

如何提高PCR?物克隆的效率

A new and sensitive method for the quantification of HBV cccDNA by real-time PCR.

Fluorescent-PCR is a new technology